- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05674110
Screening and Nutrition for Patients With Diabetes: A Pilot Study
May 13, 2024 updated by: Villanova University
Screening, Education, and Nutrition to Address Diabetes and Food Insecurity for Individuals at a Food Pantry
The goal of this project is to provide diabetes self-management education and support (DSMES) and simultaneously address food insecurity for a high-risk, ethnically diverse adult population who participate in a food pantry.
This project will utilize a Community-Based Participatory Research model (CBPR).
Community representatives will engage in project implementation by participating in designing the messaging for cultural impact and advising in study operations.
This intervention targets food pantry clients self-reporting a T2DM diagnosis or who screen positive for T2DM through on-site HbA1c testing.
Once enrolled, participants will complete self-paced web-based/mobile DSMES modules, available in English and Spanish, that include the ADCES7 (Association of Diabetes Care and Education Specialists) Self-Care BehaviorsTM.
Support through text messaging, monthly group sessions, and peer mentorship will be facilitated by nursing students, registered dietitian nutritionists (RDNs), and diabetes care and education specialists (DCES) for 12 weeks.
Participants will receive nutritious food from the pantry consistent with dietary guidelines for diabetes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Eligible patients who agree to participate in the study will be screened for diabetes via HbA1c fingerstick measurement.
Participants will receive diabetes self-management education, food items recommended by registered dietitians, peer support, monthly in-person group support sessions held at the foot pantry, and text messaging with continued education.
Data will be collected at intake.
Follow up data will be collected 90 days after enrollment.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christina R Whitehouse
- Phone Number: 610-519-6833
- Email: christina.whitehouse@villanova.edu
Study Locations
-
-
Pennsylvania
-
Villanova, Pennsylvania, United States, 19085
- Recruiting
- Villanova University
-
Contact:
- Christina R Whitehouse
- Phone Number: 610-519-6833
- Email: christina.whitehouse@villanova.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18 and older
- Existing and/or new diagnosis of T2DM
- Food pantry participants
- English and/or Spanish speaking
- Willing/able to provide informed consent
- Must have a mobile device able to receive text messages
Exclusion Criteria:
- Under the Age of 18
- No T2DM or do not meet HbA1c > 6.5 criteria
- Not a food pantry participant
- Unwilling/unable to provide informed consent
- Spoken language is other than English/Spanish
- Individuals who do not have access to a mobile device or are unable to receive text messages
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Education and Support
online education and support meetings
|
This study will provide participants with on-line education, plus weekly text messaging that will contain messages of support or encouragement sent to participants in the individual's preferred language (English or Spanish).
Participants will be encouraged to attend monthly group support meetings to review the content and address any questions.
Group meetings will occur at 3-time intervals (end of months: 1, 2, and 3).
Group support meetings will be held in-person at a food pantry and moderated by peer mentors, nursing students, registered dietitian nutritionist (RDN), and/or a diabetes care and education specialist (DCES).
Group support meetings will be held in Spanish and/or English, with no more than 10 participants in a group at one time, and will last approximately 50 minutes.
For the duration of the study, participants will continue to receive monthly food items from the food pantry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Diabetes knowledge
Time Frame: Baseline and three months
|
The Diabetes Knowledge Test (DKT2) will test change in diabetes knowledge (measured at baseline and post-intervention completion).
|
Baseline and three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Diabetes Self-Efficacy
Time Frame: Baseline and three months
|
Change in Diabetes self-efficacy will be measured with the Diabetes Self-Efficacy Scale which will measure individuals' perception of their ability to manage their diabetes (measured at baseline and post intervention completion).
|
Baseline and three months
|
|
Change in eating behaviors
Time Frame: Baseline and three months
|
Change in eating behaviors will be measured with the Food Frequency Questionnaire (FFQ) and 3 day dietary recall at 3 months (measured at baseline and post-intervention completion).
|
Baseline and three months
|
|
Change in Hemoglobin A1c
Time Frame: Baseline and six months
|
All participants will provide a fingerstick blood sample collected at 3-months following completing of the intervention.
A1C is a measure of glycemic control over the last 3 months.
|
Baseline and six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christina R Whitehouse, Villanova University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 9, 2023
Primary Completion (Estimated)
December 15, 2024
Study Completion (Estimated)
December 15, 2024
Study Registration Dates
First Submitted
December 9, 2022
First Submitted That Met QC Criteria
January 5, 2023
First Posted (Actual)
January 6, 2023
Study Record Updates
Last Update Posted (Actual)
May 14, 2024
Last Update Submitted That Met QC Criteria
May 13, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-FY2022-228
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on DSMES Intervention
-
Hoag Memorial Hospital PresbyterianCompleted
-
University of Alabama at BirminghamAmerican Diabetes AssociationNot yet recruiting
-
Recep TuranNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes Distress | Diabetes-related DistressTurkey (Türkiye)
-
University of Alabama at BirminghamNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruitingBMI | Diabetes (DM) | Weight Change | Blood Cholesterol | Diabetes Education | Blood Pressure MonitoringUnited States
-
Ramathibodi HospitalRecruiting
-
Omada Health, Inc.Palo Alto Medical Foundation; Sutter HealthTerminatedType 2 DiabetesUnited States
-
MedsPLUS ConsultingNational Institutes of Health (NIH); Lister Hill Center for Health Policy; Jenkins...Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes
-
University of ArizonaCompleted
-
Omada Health, Inc.Abbott Diabetes Care; Evidation HealthCompletedType 2 DiabetesUnited States
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedHypertension | Diabetes Mellitus | High Blood Pressure | High Blood SugarUnited States